Reduced risk of second primary cancer in patients treated with immune checkpoint inhibitors for a first cancer
Ethical approval: the work was approval by the internal review board of the Centre
Leon Bérard. Only patients not opposing to the re-analysis of their anonymized health
data within internal academic studies were included according to the standard...